Clinical Report: Inflammatory Biomarkers and Respiratory Function in Liver Transplant Patients
Overview
This study investigates the association between elevated inflammatory markers and impaired lung function in liver transplant recipients. Elevated hs-CRP levels were found to correlate with lower FEV1 and FVC, indicating systemic inflammation's potential role in respiratory impairment in this population.
Background
Liver transplant recipients are at increased risk for pulmonary complications due to immunosuppressive therapy, yet the relationship between systemic inflammation and lung function in this group remains underexplored. Understanding this association is crucial for improving post-transplant care and managing respiratory health in these patients. Elevated inflammatory markers have been linked to reduced lung function in the general population, suggesting a similar mechanism may exist in liver transplant recipients.
Data Highlights
Outcome
Findings
Airflow Limitation Prevalence
11.6%
PRISm Prevalence
24.5%
Median FEV1
2790 mL (IQR 2230–3505 mL)
Median FVC
3680 mL (IQR 2980–3755 mL)
hs-CRP >3 mg/L
aOR 2.08 for PRISm
FEV1 Reduction
-209 mL (95% CI -340; -77 mL)
FVC Reduction
-290 mL (95% CI -448 mL; -132 mL)
Key Findings
11.6% of liver transplant recipients exhibited airflow limitation.
24.5% had preserved ratio impaired spirometry (PRISm).
Median FEV1 was 2790 mL, and median FVC was 3680 mL.
hs-CRP levels >3 mg/L were associated with increased odds of PRISm (aOR 2.08).
Elevated hs-CRP correlated with significant reductions in FEV1 and FVC.
Other inflammatory markers did not show significant associations with lung function outcomes.
Clinical Implications
The findings suggest that monitoring hs-CRP levels in liver transplant recipients may provide insights into their respiratory health and risk for lung function impairment. Clinicians should consider incorporating routine spirometry and inflammatory marker assessments into the post-transplant care regimen to better manage respiratory complications.
Conclusion
Elevated hs-CRP is associated with impaired lung function in liver transplant recipients, highlighting the importance of systemic inflammation in this population's respiratory health. Further research is warranted to explore the underlying mechanisms and potential interventions.
by Nicoline Arentoft, Julie Høgh, Hans-Christian Pommergaard, Andreas Dehlbæk Knudsen, Annette Dam Fialla, Paul Suno Krohn, Niels Kristian Aagaard, Jens-Ulrik Stæhr Jensen, Jesper Rømhild Davidsen, Michael Perch, Allan Rasmussen, Susanne Dam Nielsen
